{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:03:15Z","timestamp":1790532195239,"version":"4.1.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.bcmd.2019.102402","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T12:15:36Z","timestamp":1577967336000},"page":"102402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Early initiation of high-dose oral ambroxol in combination with enzyme replacement therapy in a neuropathic Gaucher infant"],"prefix":"10.1016","volume":"81","author":[{"given":"Shao-Yin","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ching","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuh-Liang","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pen-Jung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Hsiu","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2019.102402_bb0005","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bcmd.2016.12.001","article-title":"The additive effect on the antiepileptic treatment of ambroxol in type 3 Gaucher patient. The early observation","volume":"68","author":"Pawlinski","year":"2018","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2019.102402_bb0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/acn3.292","article-title":"Ambroxol chaperone therapy for neuronopathic Gaucher disease: a pilot study","volume":"3","author":"Narita","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.bcmd.2019.102402_bb0015","first-page":"3750","article-title":"Individualized screening for chaperone activity in Gaucher disease using multiple patient derived primary cell lines","volume":"10","author":"Ivanova","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bcmd.2019.102402_bb0020","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/ijns4040041","article-title":"Performance of the four-Plex tandem mass spectrometry lysosomal storage disease newborn screening test: the necessity of adding a 2nd tier test for Pompe disease","volume":"4","author":"Chiang","year":"2018","journal-title":"International Journal of Neonatal Screening"},{"key":"10.1016\/j.bcmd.2019.102402_bb0025","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.bcmd.2006.02.001","article-title":"Mutation analysis of Gaucher disease patients in Taiwan: high prevalence of the RecNciI and L444P mutations","volume":"36","author":"Wan","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"10.1016\/j.bcmd.2019.102402_bb0030","article-title":"Pharmacologic properties of high-dose ambroxol in four patients with Gaucher disease and myoclonic epilepsy","author":"Kim","year":"2019","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.bcmd.2019.102402_bb0035","article-title":"Effect of Ambroxol chaperone therapy on Glucosylsphingosine (Lyso-Gb1) levels in two Canadian patients with type 3 Gaucher disease","volume":"20","author":"Charkhand","year":"2019","journal-title":"Mol Genet Metab Rep"}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979619304930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979619304930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:34:29Z","timestamp":1761050069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979619304930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":7,"alternative-id":["S1079979619304930"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2019.102402","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early initiation of high-dose oral ambroxol in combination with enzyme replacement therapy in a neuropathic Gaucher infant","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2019.102402","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102402"}}